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A r t i c l e s
Chitinase-like proteins (CLPs) are associated with a range of pathologies and are among the most abundant proteins found under conditions of type 2 activation of the immune system, but their functions remain poorly understood 1 . CLPs are members of a family that include both chitotriosidase and acidic mammalian chitinase, enzymes that cleave chitin, which is a widespread structural component of arthropods, parasites and fungi. Consistent with the function of chitinases throughout the evolutionary tree 1 , active chitinase enzymes act to defend the host against chitin-containing pathogens [2] [3] [4] . CLPs, however, are catalytically inactive due to loss-of-function mutations 5 . Evolutionarily recent gene-duplication events in mammals have resulted in expansion and diversification of the CLP-encoding genes such that each mammalian species exhibits a different array of CLP-encoding genes 5 . Mice have three CLPs (Ym1, Ym2 and BRP-39), while humans have two (YKL-39 and YKL-40). The rapid divergence of CLPs in mammalian species indicates a role for these proteins in host defense, but their expression patterns in many non-infectious settings 1, 6 precludes the possibility that defense against pathogens is their sole function.
The mouse proteins Ym1 (encoded by Chil3) and Ym2 (encoded by Chil4) were the first CLPs to be identified as mediators of T helper type 2 (T H 2) inflammation in allergy 7, 8 . Despite extensive publications describing increased expression of Ym1 during a wide range of pathologies, Ym1 is often disregarded as an important participant in CLP biology because of the lack of a true human ortholog of Ym1 and/or Ym2. Instead, emphasis has been placed on mouse BRP-39 (encoded by Chil1), which has the human homolog YKL-40 (encoded by CHI3L1). Studies of transgenic mouse models have shown that both BRP-39 and YKL-40 can contribute to the pathology of airway disease [9] [10] [11] [12] . Because expression of all three mouse CLPs is upregulated in response to T H 2-driven inflammation in the lungs of mice, studying BRP-39 in isolation may not reveal the true functions of this closely related protein family.
We aimed to understand the general biology of CLPs by considering them as a family rather than by studying each in isolation. Our results revealed an unexpected role for Ym1 and, to some extent, Ym2 in driving the recruitment of neutrophils into the lungs, due to the ability of Ym1 and Ym2 to increase the number of γδ T cells that expressed interleukin 17A (IL-17A). Although BRP-39 did not significantly influence neutrophil numbers, like Ym1 and Ym2, it did alter IL-17 expression in the models tested, which indicated that the ability to modulate IL-17 is a key feature of all three CLPs. We further demonstrated that the recruitment of neutrophils observed during the migration of Nippostrongylus brasiliensis through the lungs was mediated mainly by Ym1 in an IL-17-dependent manner. The Ym1-induced neutrophilia contributed to acute lung damage but, unexpectedly, Ym1 and IL-17 also impaired parasite survival. We thus highlight an anti-parasite effector mechanism by which Ym1 negatively influences the integrity of parasites through IL-17-mediated recruitment of neutrophils but at a cost of increased lung damage.
RESULTS

Ym1 is the dominant CLP in the lungs
We examined the expression of Chil1, Chil3 and Chil4 in the lungs of BALB/c mice during T H 2 responses that resulted from ovalbumin
Ym1 overexpression results in lung neutrophilia
All CLPs exhibited increased expression during lung pathology, yet the function of these molecules, particularly Ym1 and Ym2, remained elusive. Therefore, we developed an overexpression model to directly assess the function of Ym1, Ym2 and BRP-39. We administered plasmids encoding CLPs in complex with polyethylenimine intranasally to mice and monitored transfection by quantitative RT-PCR of lung tissue. As expression peaked between 24 h and 48 h (data not shown), we chose 48 h as the time point for all subsequent analyses.
The number of macrophages containing microscopically observable particulate matter (corresponding to plasmid complexes) in mice that received the plasmid directly correlated with protein expression assessed by enzyme-linked immunosorbent assay (data not shown); thus, we used this as an indirect measure of transfection for all experiments. Approximately 35-40% of macrophages in the bronchoalveolar lavage (BAL) fluid contained complexes, independently of the plasmid administered (data not shown). To confirm selective overexpression, we measured the abundance of Chil1, Chil3 and Chil4 mRNA in total cells in BAL fluid. While transfection with empty vector (pcDNA3.1) did not alter the expression of CLP-encoding mRNA relative to that in naive mice (data not shown), after transfection with CLP-encoding plasmids, we found up to approximately 1000-fold specific overexpression of the relevant CLP-encoding mRNA (Fig. 2a) .
We examined the composition of cells of the immune system in BAL fluid and lungs 48 h after plasmid administration and found that although the administration of plasmids encoding CLPs in complex with polyethylenimine did not change the abundance of total cells in the BAL fluid or lungs (Fig. 2b,c) , neutrophil numbers were increased significantly following exogenous Ym1 expression (Fig. 2d-f) . The absolute number of CD4 + or CD8 + T cells and CD19 + B cells was not altered in the lungs of transfected mice, but eosinophil numbers were significantly reduced by exogenous Ym1 expression (P < 0.05, compared with vector alone (analysis of variance (ANOVA) with the Tukey-Kramer honest significant difference (HSD) multiplecomparison test); Supplementary Fig. 1a-d) . Thus, exogenous expression of Ym1 in the lungs resulted in increased numbers of neutrophils and reduced numbers of eosinophils.
Ym1 neutralization reduces neutrophilia and IL-17
Specific inhibition of acidic mammalian chitinase markedly increases neutrophil numbers in the lungs, accompanied by increased Ym1 expression 13 . Our observation that exogenous Ym1 induced lung Fig. 2 ) and a mouse monoclonal antibody raised against a peptide in the Ym1 sequence that has been shown to be neutralizing 14 . Although the peptide sequence is derived from Ym1, there is a difference between Ym1 and Ym2 of only one amino acid and therefore the antibody might also have activity against Ym2. We treated OVA-sensitized BALB/c mice with the antibody to Ym1 peptide (anti-Ym1) or with immunoglobulin G2a (IgG2a) isotypematched control antibody during aerosol challenge with either PBS or OVA (Supplementary Fig. 2 ) and assessed the recruitment of cells to BAL fluid. OVA challenge increased the number of total cells in the BAL fluid as well as the frequency of eosinophils and neutrophils among those cells (Fig. 3a) . Allergic eosinophilia remained unaffected by treatment with anti-Ym1 (Fig. 3a) , as did goblet-cell hyperplasia and the enhanced respiratory pause (data not shown). However, the frequency of neutrophils was lower in OVA-challenged mice treated with anti-Ym1 than in those treated with IgG2a (Fig. 3a) . Total neutrophil numbers were also reduced (1.53 × 10 5 ± 0.24 × 10 5 neutrophils in mice treated with IgG2a versus 0.91 × 10 5 ± 0.28 × 10 5 neutrophils in mice treated with anti-Ym1 (P < 0.05 (Students t-test); pooled from two independent experiments with 11-12 mice per group (mean ± s.e.m.)).
Both innate IL-17 production and adaptive IL-17 production are key processes involved in promoting the survival, recruitment and activation of neutrophils via the regulation of target genes encoding cytokines and chemokines 15 . Although IL-17 is more typically associated with host defense against microbial infection, understanding of the importance of IL-17, and indeed neutrophils, during the pathogenesis of inflammatory lung diseases, including allergy and asthma, has emerged from research over the past decade 16 . Therefore, we investigated whether treatment of allergic mice with anti-Ym1 altered the expression of IL-17A as well as genes that are targets of IL-17. The secretion of OVA-specific IL-17A stimulated by anti-CD3 in thoracic lymph node cultures was greater in allergic mice than in control mice treated with PBS, a response attenuated by treatment with anti-Ym1 (Fig. 3b) . Similarly the abundance of Il17a mRNA was significantly lower in the lungs of allergic mice treated with anti-Ym1 than in those treated with IgG2a ( Fig. 3c) , as was mRNA of the IL-17 target genes encoding the neutrophil chemotactic factors CXCL5 (Cxcl5) (Fig. 3c) and CCL3 (Ccl3) (P < 0.01, compared with treatment with OVA and IgG2a (ANOVA followed by the Kruskal-Wallis test); data not shown). Thus, the allergic lung-inflammation model suggested that Ym1 regulated neutrophil numbers through changes in the expression of IL-17A and genes that are targets of IL-17A.
gd T cells are the source of IL-17A induced by CLPs To determine whether the effects of Ym1 and Ym2 on IL-17 were lung specific or applied more broadly, we used the same transfection conditions we used for studying the lungs (Fig. 2) and injected CLP-encoding plasmid, control plasmid (pcDNA3.1) or vehicle (5% glucose) into the peritoneal cavity. Approximately 20% of peritoneal macrophages and/or monocytes from transfected mice contained particulate matter corresponding to plasmid complexes (data not shown), and analysis of mRNA abundance in peritoneal cells revealed specific overexpression of each individual CLP-encoding mRNA (Fig. 4a) . Of note, transfection with the plasmid encoding Ym1 increased the expression of both Chil1 mRNA and Chil4 mRNA (Fig. 4a) , which suggested that members of the CLP family might have the ability to regulate each other.
Unlike the lung-transfection model, injection of plasmid into the peritoneal cavity caused significantly more accumulation of inflammatory cells than did injection of glucose alone (Fig. 4b) . This probably reflected the uniquely high threshold of responsiveness to inflammatory stimuli in the lungs 17 . Nonetheless, the total number of peritoneal exudate cells (PECs) was higher following transfection with plasmid encoding Ym1 or Ym2 than after transfection with the control plasmid (Fig. 4b) . While transfection in general increased the number of neutrophils, this effect was significantly enhanced when either Ym1 or Ym2 was overexpressed (Fig. 4b) . The increased number of neutrophils was mirrored by an increase in Il17a expression in total PECs (Fig. 4c) .
To identify the source of IL-17A following transfection with plasmid encoding Ym1 or Ym2, we stimulated total PECs ex vivo with the phorbol ester PMA plus ionomycin and stained intracellular IL-17A in the cells. Only a very small frequency of CD4 + or CD8 + T cells were Fig. 3a ). Of note, transfection with plasmid encoding any of the CLPs resulted in more γδ T cells as well as IL-17A-producing γδ T cells than did transfection with control plasmid (Fig. 4d,e) . We demonstrated that γδ T cells were the source of IL-17A following exogenous exposure to Ym1, not only in the peritoneal cavity but also in the lungs (Supplementary Fig. 3b ). Both IL-1β and IL-18 can act in synergy with IL-23 to stimulate γδ T cells to produce IL-17A 18 , so we assessed the expression of these cytokines in PECs from transfected mice. While we did not detect mRNA encoding the p19 α-subunit of IL-23 (Il23a mRNA; called 'Il23p19 mRNA' here) in PECs (data not shown), transfection with plasmid encoding Ym1 or Ym2 increased the expression of both Il1b and Il18 (Fig. 4f,g ). Overexpression of BRP-39 significantly increased the abundance of Il18 mRNA but not that of Il1b mRNA (Fig. 4f,g ), which might explain the smaller effect of BRP-39 on IL-17A production than that of Ym1 or Ym2 (Fig. 4c,e) .
Because of the connection between IL-1β expression and the induction of IL-17-producing γδ T cells 18, 19 , we assessed whether blockade of the IL-1 receptor altered the effect of CLPs; for this we used anakinra, an antagonist of the IL-1 receptor 20 . Treatment with anakinra significantly reduced the ability of Ym1 to induce IL-17-producing γδ T cells in the peritoneal cavity ( Fig. 4h and Supplementary Fig. 3c ) (Fig. 4i) . Of note, anakinra also prevented the suppression of IFN-γ following Ym1 overexpression (Supplementary Fig. 3d ), which might have contributed to the enhanced IL-17 production in the presence of Ym1. Notably, the ability to suppress IFN-γ might be a general feature of Ym1, as treatment with anti-Ym1 elevates IFN-γ production by CD8 + T cells during coinfection with helminth and virus 21 .
Along with subsets of γδ T cells, innate lymphoid cells (ILCs) are an important source of IL-17A that promote inflammation and immunity 22, 23 . Analyzing the cellular composition of the peritoneal cavity, we detected a small population of IL-17A + ILCs in both BALB/c wild-type mice and mice deficient in the recombinase component RAG-2 (Supplementary Fig. 4a,b) . However, overexpression of Ym1 did not influence either the total number of ILCs or the number that expressed IL-17A (Supplementary Fig. 4b) . Furthermore, Ym1 failed to recruit neutrophils into the peritoneal cavity of RAG-2-deficient mice (Supplementary Fig. 4c ), which provided further evidence that γδ T cells rather than ILCs were the critical source of IL-17A. Collectively, our results suggested that Ym1 and Ym2 coordinated the recruitment of neutrophils in vivo by stimulating γδ T cells to produce IL-17A, via the induction of IL-1 and possibly IL-18. BRP-39 was also able to influence the number of IL-17A-producing γδ T cells in the peritoneal cavity (Fig. 4d,e) , but this signal alone was not sufficient to substantially influence neutrophil recruitment in these models.
Ym1 contributes to N. brasiliensis-induced lung injury
Helminth infection induces strong T H 2 immunity. However, the initial acute response to the nematode N. brasiliensis, which migrates to the lungs, involves tissue damage, neutrophilic inflammation and hemorrhage 24 . Published work has highlighted not only the contribution of neutrophils to nematode-induced lung damage but also the role of alternatively activated macrophages in repairing that damage 24 . Since Ym1 is one of the molecules most abundantly produced by macrophages in this setting, it has been predicted to contribute to that repair. However, our unexpected finding that Ym1 induced neutrophilia suggested that Ym1 might instead contribute to acute lung injury. To investigate this, we infected BALB/c mice with 500 infective larvae of N. brasiliensis (third-stage larvae (L3)) and treated the mice systemically with either anti-Ym1 or isotype-matched control antibody. The number of neutrophils in BAL fluid (Fig. 5a ) and lung tissue (Fig. 5b) was greater at day 2 following infection and lower by day 4. Consistent with our data obtained by transfection and for allergic airway inflammation, treatment with anti-Ym1 prevented the influx of neutrophils into the airways, and such treatment also reduced the npg A r t i c l e s number of neutrophils in the lung tissue at day 2 ( Fig. 5a,b) . The number of alveolar macrophages and lung interstitial macrophages in BAL fluid was also lower in infected mice at day 2 following treatment with anti-Ym1 than following treatment with the control antibody IgG2a, an effect that was no longer apparent at day 4, at which point mice had not received antibody treatment for 72 h (Fig. 5a,b) . The changes in the number of neutrophils following treatment with anti-Ym1 were mirrored by a reduction in the expression of Il17a (Fig. 5c) and the IL-17A-target chemokine-encoding genes Cxcl5 (Fig. 5d) , Ccl3 and Cxcl1 (data not shown) in the lung tissue of mice at day 2 after infection. Additionally, the secretion of IL-17A from splenocytes stimulated ex vivo with N. brasiliensis excretory secretory products at day 4 after infection was reduced by treatment with anti-Ym1 (Supplementary Fig. 5a ), which suggested an altered adaptive IL-17 response to the worm antigen. The expression of Il23p19 increased in the lungs following infection but was not altered by treatment with anti-Ym1 (data not shown). However, as expected, the expression of Il1b mRNA in the lungs was attenuated by treatment with antiYm1 (Fig. 5e) . Although the amount of IL-1β protein in whole-lung homogenates was significantly increased only at day 4 after infection in mice treated with IgG2a, treatment with anti-Ym1 reduced the abundance of IL-1β at day 2 relative to treatment with the control antibody IgG2a (Fig. 5f) .
We next investigated whether the attenuated expression of IL-17A and reduced neutrophilia following treatment with anti-Ym1 affected acute lung injury. Histological assessment showed alveolar destruction and tissue hemorrhage at day 2 after infection with N. brasiliensis and the initiation of repair and accumulation of inflammatory foci by day 4 (Fig. 5g) . Treatment with anti-Ym1 diminished the tissue destruction observed at day 2 (P < 0.01, compared with treatment with OVA and IgG2a (ANOVA followed by the Tukey-Kramer HSD multiple-comparison test), as quantified by 'linear means intercept' , a measurement of airspace enlargement. The effect of treatment with anti-Ym1 was no longer evident at day 4.
If Ym1 were acting via IL-17A, then IL-17A deficiency would mimic treatment with anti-Ym1 during the early stages of infection. To investigate this, we studied mice homozygous for insertion of a transgene expressing Cre recombinase into the endogenous Il17a gene (Il17a Cre ) that were therefore deficient in IL-17A production, and that also expressed enhanced yellow fluorescent protein (eYFP) from the ubiquitous Rosa26 locus (Rosa26 eYFP ) as a reporter of Cre activity 25 . We infected those Il17a Cre Rosa26 eYFP mice and C57BL/6 wild-type mice with 500 N. brasiliensis larvae (L3) and assessed their responses at days 2 and 4 after infection. At day 2, wild-type mice had the characteristic increase in the number of neutrophils in BAL fluid but, as expected, the IL-17A-deficient mice failed to recruit neutrophils into the BAL fluid at day 2 after infection ( Fig. 6a) . Similar to published reports on the role of IL-17A during acute lung injury 24, 26 , the IL-17A-deficient mice were protected from the peak of tissue damage at day 2 following infection with N. brasiliensis (Fig. 6b) . However, despite the lower initial damage in the IL-17A-deficient mice, their lungs failed to repair appropriately by day 4, in contrast to the adequate repair in wild-type mice (Fig. 6b) . This may have been related to our finding that IL-13 production was also significantly lower in IL-17A-deficient mice than in wild-type mice (Fig. 6c) . Notably, treatment with anti-Ym1 also prevented this early antigen-specific IL-13 response (Supplementary Fig. 5b) .
Flow cytometry assessing intracellular IL-17A in wild-type mice allowed us to demonstrate that as in the peritoneal cavity, γδ T (Fig. 6d,e) . We obtained similar results when we examined eYFP expression in lung-cell suspensions from infected Il17a Cre Rosa26 eYFP mice (Supplementary Fig. 6 ). Not only did we observe an increase in the number of IL-17A-secreting γδ T cells but also the absolute number of all γδ T cells was increased at both day 2 and day 4 following infection ( Fig. 6e) . Together these N. brasiliensis studies revealed that Ym1 induced IL-17A-producing γδ T cells, which, via IL-1, promoted the accumulation of neutrophils and thus contributed to acute lung injury associated with the migration of larvae through the lungs.
BRP-39 regulates IL-17 expression but not neutrophilia
Although overexpression of BRP-39 did not influence the number of neutrophils, it did result in enhanced IL-17A production in the peritoneal cavity and an increased number of IL-17-producing γδ T cells (Fig. 4) . Because this overlapped the observed effects of Ym1, we sought to determine whether the CLP family had common influences on IL-17A. We therefore infected Chil1 −/− mice and C57BL/6 wild-type mice with N. brasiliensis and assessed their responses at days 2 and 4 after infection. The abundance of Il17a transcripts in the lungs increased over the duration of infection in wild-type mice, as we had previously seen (Fig. 5c) . In contrast, we detected almost no Il17a mRNA in Chil1 −/− mice at day 2 and detected much less Il17a mRNA in Chil1 −/− mice than in wild-type mice at day 4 (Fig. 7a) . Additionally, both the total number of γδ T cells and the number of IL-17A-producing γδ T cells were significantly lower in Chil1 −/− mice than in wild-type mice (Fig. 7b) . Despite such differences in IL-17A-producing γδ T cells, there were no such observable differences in the number of lung neutrophils (Fig. 7c) or the expression of Il1b, Il23p19 or Il18 (Fig. 7d) or of Cxcl5 or Ccl3 (data not shown). Thus, not unexpectedly, there were no differences between Chil1 −/− mice and wild-type mice in terms of tissue damage (data not shown).
Ym1 contributes to innate anti-nematode defense
Our data demonstrated that neutralization of Ym1, depletion of neutrophils or IL-17 deficiency during infection with N. brasiliensis limited acute lung injury, results supported by published studies of the roles of neutrophils and IL- 17 (refs. 24,27) . However, the diminished neutrophilia and resultant lung injury could have reflected changes in the number of larvae that reached the lung. We therefore assessed the expression of N. brasiliensis-specific actin-encoding mRNA in whole lungs. While such a measurement cannot distinguish between live larvae and dead larvae, it did indicate that at day 2 after infection, at the peak of lung injury, a similar number of larvae had entered the lungs of mice treated with isotype-matched control antibody and those treated with anti-Ym1 (Fig. 8a) , as well as IL-17A-deficient mice (Fig. 8b) and Chil1 −/− mice (Fig. 8c) . Therefore, the differences in neutrophilia and acute lung injury could not be explained by a reduction in the number of worms that reached the lungs. We additionally assessed worm burden in the small intestine at day 4 after infection. The data showed that treatment with anti-Ym1 increased the number of larvae reaching the gut by approximately twofold compared with treatment with control antibody (Fig. 8d) . IL-17A-deficient mice also exhibited a greater worm burden in the small intestine at day 4 than that of wild-type mice (Fig. 8e) , with a phenotype similar to that resulting from blockade of Ym1 (Fig. 8d) . Despite the lower IL-17A production in Chil1 −/− mice infected with N. brasiliensis than in their infected wild-type counterparts, we observed no differences in worm burden (Fig. 8f) , which suggested a role for neutrophils in resistance to parasites. The possibility of a role for neutrophils in the assault on the parasite was supported by histological analysis of neutrophils in the lungs of mice treated with anti-Ym1 versus those treated with isotype-matched control antibody (Fig. 8g) . In lung sections of all mice, we observed organized 'swarms' of neutrophils around larvae, but the number of neutrophil swarms (Fig. 8h) and their size (Fig. 8i) was significantly lower in mice treated with anti-Ym1 than in those treated with the isotypematched control antibody. Frequency distribution analysis further illustrated that not only did mice treated with anti-Ym1 have fewer swarms than did mice treated with isotype-matched control antibody but also those swarms contained only 50-100 neutrophils and did not achieve the large number of neutrophils seen in mice treated with control antibody (Fig. 8j) . To provide further evidence that Ym1 was sufficient to enhance parasite resistance, we transfected mice with plasmid encoding Ym1 to increase protein abundance and the number of neutrophils in the lungs before infection with N. brasiliensis larvae (L3). The number of parasites was significantly lower in the intestines of mice in which Ym1 was overexpressed in the lungs than in mice transfected with the empty vector (Fig. 8k) . Of note, in terms of parasite recovery, the difference between mice transfected with empty vector and those transfected with plasmid encoding Ym1 increased as the worms migrated through the intestine (Fig. 8l) , which suggested that exposure to Ym1 and neutrophils in the lungs had compromised the Fig. 3c ). *P < 0.05, **P < 0.01 and ***P < 0.001, compared with uninfected wild-type mice or wild-type mice on day 2 or day 4 after infection (a-c), †P < 0.01, compared with wild-type mice on day 4 infection (b) (ANOVA with the Tukey-Kramer HSD multiple-comparison test). Data are representative of two independent experiments with six to twelve mice per group (mean and s.e.m.).
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A r t i c l e s fitness of the parasite. Overall, the increase in the number of parasites in the gut demonstrated that Ym1 and IL-17A were involved in limiting parasite burden (probably through actions on neutrophils), but at the cost of enhanced lung damage (Supplementary Fig. 7) . DISCUSSION Neutrophils and the T H 17 subset of helper T cell are regarded as important inflammatory cells in patients with chronic severe asthma or steroid-resistant asthma [28] [29] [30] , and expression of the human CLP YKL-40 is increased during chronic obstructive pulmonary disease 31 and active colitis 32 , conditions that are also associated with responses by T H 17 cells and neutrophils 33, 34 . YKL-40 expression in children with severe, steroid-resistant asthma or patients with cystic fibrosis correlates with neutrophil abundance 11, 35 , which contributes to the notion that CLPs regulate neutrophilic inflammation during pathology. Our studies with direct transfection demonstrated the ability of all three mouse CLPs to induce the expansion of IL-17-producing γδ T cell populations. In support of a model in which regulation of the IL-17 pathway is an inherent feature of the mouse CLP family, both Chil1 −/− mice and mice treated with anti-Ym1 failed to upregulate their expression of Il17a mRNA in the lungs at day 2 following infection with N. brasiliensis. Unlike the effect of Ym1, the influence of BRP-39 in these settings was not sufficient to influence the number of neutrophils. Notably, our findings are consistent with studies showing a correlation between the expression of IL-17A and the expression of both BRP-39 and Ym1 (refs. 36,37) .
From an evolutionary standpoint, a role for enzymatically inactive CLPs in innate immunity is not altogether unexpected, given that their close 'relatives' contribute to immunological defense through the degradation of chitin from invading pathogens 38 and BRP-39 has been shown to contribute to defense against Streptococcus pneumonia 36 . Here we found that Ym1 and Ym2, through the regulation of IL-17-producing γδ T cells and neutrophils, served a crucial host-protective role by limiting nematode burden. Notably, γδ T cells are similarly triggered to produce IL-17A following the administration of chitin in the lungs 19 , but the involvement of CLPs was not explored in those studies. While control of helminth infection is typically dependent on T H 2 immunity 39 , there is growing evidence that neutrophils contribute to killing nematodes 40, 41 . Of note, Ym1 enhanced not only the number of neutrophils but also the number of alveolar and interstitial macrophages in the lungs at day 2 after infection. Therefore, Ym1 might control parasite worm burden by directing both neutrophils and macrophages to damage larvae in the skin or lungs before they reach the gut.
Because neutrophils and IL-17 contribute to the lung damage associated with the migration of N. brasiliensis larvae 24 , we assessed the lung condition of infected mice treated with anti-Ym1. Such treatment blocked the influx of neutrophils into both the interstitial spaces and npg A r t i c l e s the bronchoalveolar spaces, as well as the expression of genes encoding IL-17A and IL-17-driven chemokines in mice at day 2 after infection. As predicted by published work 24 , this resulted in significantly less acute lung injury, an effect mirrored in mice deficient in IL-17A. Thus, Ym1 in the early innate stages of infection with N. brasiliensis promoted lung damage, presumably as a necessary consequence of limiting the number of parasites. While the finding that a strongly T H 2-associated protein was able to drive the accumulation of neutrophils and contribute to injury responses may be somewhat unexpected, Ym1 has consistently been associated with acute injury 42, 43 , and indeed one of the first publications on Ym1 showed rapid Ym1 expression following a stab wound in the brain 44 . Such data, along with the ability of Ym1 and Ym2 to upregulate the expression of IL-1β and the number and activity of early responder γδ T cells, indicate Ym1 and Ym2 are danger-associated molecular patterns that form part of the innate immune response to trauma 45 . The possibility that CLPs act as danger-associated molecular patterns is supported by the finding that the induction of IL-17 and neutrophils was dependent on IL-1 signaling. Although Ym1 induced the release of IL-1 from peritoneal cells in vitro, the amount was far below that observed with well-known inflammasome activators (data not shown). We thus suspect that Ym1 was interacting with other components in vivo or was triggering the release of IL-1 from other sources, such as epithelial cells or platelets. CLPs are lectins that can bind heparan sulfate in the extracellular matrix and on the cell surface 46 , and this might contribute to the release of IL-1 via receptor crosslinking or displacement of extracellular matrix-bound inflammasome mediators. Additionally, Ym1 has the propensity to form crystals in pathological conditions 47 , which might directly activate the inflammasome in vivo but not under our in vitro conditions. These will be important avenues for further investigation, along with specific assessment of the contributions of IL-1α versus IL-1β and the potential role of IL-18, as well as suppressed production of IFN-γ.
Despite its contribution to neutrophil-mediated injury, a role for Ym1 in subsequent repair would be predicted from its very abundant production by IL-4-activated macrophages 48, 49 , and indeed this may be the case. At approximately day 4 after infection with N. brasiliensis, the immune response starts to switch to an adaptive one, with an increase in T H 2 cytokine expression 24, 50 , required for the expulsion of worms 51 . The repair of lung damage from larval migration also requires a competent host adaptive response 52 and signaling via the receptor IL-4Rα 24 as well as an intact population of type 2 ILCs 53 . Notably, the chitin-driven γδ T cell response that has been reported was dampened by activated type 2 ILCs 19 . We saw no change in the number of ILCs in the short time frame of the infections with N. brasiliensis, but given that chitin is a structural component of many pathogens, including helminths, the ability to restrain excessive γδ T cell stimulation and the ensuing neutrophilic inflammation would be necessary for limiting damage to the host. Indeed, our data suggested that IL-17 itself would be able to promote the protective type 2 response, as IL-17A-deficient mice showed diminished type 2 cytokine responses and there seemed to be defects in lung repair at day 4. The idea that IL-17 can promote type 2 responses in the lung is not new and has been reported [54] [55] [56] . While our study has focused on the early innate events, further investigation would be needed to determine whether the Ym1-, Ym2-or even BRP-39-mediated production of IL-17A contributes to later repair responses.
The chromosomal location of CLP-encoding genes suggests that mouse and human CLPs are derived from the duplication and mutation of genes encoding the active chitinases 5 . Thus, despite the differences between species, CLPs as a family probably share common features. Elucidating why CLPs are undergoing such rapid divergence is an important challenge for understanding their function relative to that of their non-mutating enzymatically active relatives. Our studies have defined a previously unknown role for CLPs in innate immune defense against nematodes. In summary, we found that mouse CLPs promoted IL-17 responses and that Ym1 led to enhanced recruitment of neutrophils. The consequence of Ym1 function on infection with a nematode that migrates to the lungs was better control of the parasite but at the cost of increased acute lung damage.
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